While preliminary safety data appears promising, more comprehensive human studies are needed to establish definitive dosing guidelines and safety parameters
doi: 10.1080/00365521.2016.1192678
While increased adiposity (i.e., overweight and obesity) is the usual driver of IR, other factors may play a role in the development of IR in T1D
Watson CJ, Whitledge JD, Siani AM, Burns MM
Para continuar, acessesua conta trace-id: e6c98638-a2a6-4483-bbf6-d2938237d77c Usamos cookies para melhorar sua experincia no Mercado Livre
However, potential side effects may include: Mild flushing or warmth during administration Temporary changes in heart rate or blood pressure Headache or nausea (usually mild and transient) It's crucial to receive NAD+ injections from a qualified healthcare provider to ensure proper dosing and administration